Overview

Relative Bioavailability of NXP001 Compared to Emend® in Healthy Volunteers

Status:
Completed
Trial end date:
2019-04-30
Target enrollment:
Participant gender:
Summary
This study will compare the relative bioavailability of both an oral capsule formulation and an oral suspension formulation of NXP001 to Emend® in healthy male volunteers in the fasted state.
Phase:
Phase 1
Details
Lead Sponsor:
Nuformix Technologies Limited
Treatments:
Aprepitant